Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,785 shares at $3.11 ($5K) on 2021-08-05, disclosed to the SEC on 2021-09-10.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.34 | 85 | $284 | 5.3% |
| 2 | $3.17 | 85 | $269 | 5.1% |
| 3 | $3.18 | 85 | $270 | 5.1% |
| 4 | $3.11 | 85 | $264 | 5.0% |
| 5 | $3.01 | 85 | $256 | 4.8% |
| 6 | $2.93 | 85 |
| $249 |
| 4.7% |
| 7 | $2.96 | 85 | $252 | 4.7% |
| 8 | $2.98 | 85 | $253 | 4.8% |
| 9 | $2.92 | 85 | $248 | 4.7% |
| 10 | $2.92 | 85 | $248 | 4.7% |
| 11 | $3.05 | 85 | $259 | 4.9% |
| 12 | $2.97 | 85 | $252 | 4.7% |
| 13 | $3.02 | 85 | $257 | 4.8% |
| 14 | $2.96 | 85 | $252 | 4.7% |
| 15 | $2.87 | 85 | $244 | 4.6% |
| 16 | $2.89 | 85 | $246 | 4.6% |
| 17 | $2.79 | 85 | $237 | 4.5% |
| 18 | $2.82 | 85 | $240 | 4.5% |
| 19 | $2.84 | 85 | $241 | 4.5% |
| 20 | $2.88 | 85 | $245 | 4.6% |
| 21 | $2.93 | 85 | $249 | 4.7% |
| Total | $2.98 avg | 1,785 | $5K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |